Current Report Filing (8-k)
07 February 2023 - 12:01AM
Edgar (US Regulatory)
0001140215
false
0001140215
2023-02-06
2023-02-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 6, 2023
REED’S,
INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
001-32501 |
|
35-2177773 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
201
Merritt 7, Norwalk, CT 06851
(Address
of principal executive offices and zip code)
Not
applicable
(Former
name or former address if changed since last report)
Registrant’s
telephone number, including area code: (203) 890-0557
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title
of Each Class |
|
Trading
Symbol(s) |
|
Name
of Each Exchanged on Which Registered |
Common Stock, $.0001 par
value per share |
|
REED |
|
The NASDAQ Stock Market
LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
(c)
Reed’s, Inc., a Delaware corporation (“Reed’s” or the “company”) announced today the appointment
of Christopher Burleson, age 41, as Chief Commercial Officer, effective February 1, 2023. In this role, Mr. Burleson will lead the sales
organization as well as partner with the operations department to streamline supply chain and cost reductions initiatives. He will also
focus on strategic partnerships and growth opportunities.
From
April 25, 2022 to January 31, 2023, Mr. Burleson served as Chief Commercial Officer of Kin Social Tonics. From March 19, 2018 through
April 22, 2022, Mr. Burleson was a Vice President and General Manager of Fever Tree, USA. Mr. Burleson also served as a director of Fever
Tree USA.
Mr.
Burleson will receive a salary of $300,000 and will be eligible for an annual performance bonus based on a target of 35% of his annual
salary (to be determined by the company in its sole discretion). As an inducement to accept the position, Mr. Burleson will receive a
vested RSA grant of approximately 18,160 shares of common stock of Reed’s valued at $75,000 pursuant to the Reed’s, Inc.
2020 Equity Incentive Compensation Plan, as amended December 30, 2021. Mr. Burleson will not participate in the company’s health
insurance benefits. He will however be eligible to receive 4 weeks of paid vacation and may participate in the company’s incentive
stock option program. He will also be eligible to receive an $800 car allowance and $150 allowance towards cell phone and internet costs.
There
are no arrangements or understandings between Mr. Burleson and any other person pursuant to which Mr. Burleson was selected as an officer
of Reed’s. There are no family relationships between any director, executive officer, or Mr. Burleson. There are no transactions,
since the beginning of Reed’s last fiscal year, or any currently proposed transaction, in which Reed’s was or is to be a
participant and the amount involved exceeds the lesser of $120,000 or one percent of the average of Reed’s total assets at year-end
for the last two completed fiscal years, and in which Mr. Burleson had or will have a direct or indirect material interest.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
REEDS, INC., |
|
a Delaware corporation |
|
|
|
Dated: February 6, 2023 |
By: |
/s/ Thomas
J. Spisak |
|
|
Thomas J. Spisak, |
|
|
Chief Financial Officer |
Reeds (NASDAQ:REED)
Historical Stock Chart
From Nov 2024 to Dec 2024
Reeds (NASDAQ:REED)
Historical Stock Chart
From Dec 2023 to Dec 2024